Literature DB >> 16410218

Spinal chondromyxoid fibroma of C2.

Arul Bala1, Peter Robbins, Neville Knuckey, George Wong, Gabriel Lee.   

Abstract

Chondromyxoid fibroma of bone (CMF) is a rare benign primary bone neoplasm accounting for less than 0.5% of all primary bone neoplasms. The spine is an uncommon site for this tumour, with forty-two cases reported in the modern English literature. They have clinical features similar to CMF arising at other sites. Local recurrence is well documented. We report an incidentally discovered lytic lesion of the C2 vertebra. The patient underwent stereotactic CT guided trans-oral curettage of the lesion with iliac bone graft and anterior fusion of C2 and C3. Microscopic examination of the surgical specimen demonstrated CMF. This is the second reported case of this rare tumour in this location. We review the literature and the unique radiological and pathological features and management of spinal CMF. Local recurrence of spinal CMF and its management is also discussed in light of the five previously reported cases of local spinal recurrence.

Entities:  

Mesh:

Year:  2006        PMID: 16410218     DOI: 10.1016/j.jocn.2005.03.022

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Chondromyxoid fibroma of the skull base invading the occipitocervical junction: report of a unique case and discussion.

Authors:  Matthew Crocker; Robert Corns; Istvan Bodi; Antoine Zrinzo; Michael Gleeson; Nick Thomas
Journal:  Skull Base       Date:  2010-03

2.  Chondromyxoid fibroma of the cervical spine: A case report.

Authors:  Cheng Li; Sen Li; Wei Hu
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Chondromyxoid Fibroma of Two Cervical Vertebrae with Involvement of Surrounding Soft Tissue: Radiologic Diagnostic Dilemma.

Authors:  Shokouh Taghipour Zahir; Naser Sefidrokh Sharahjin; Farzad Sadlu Parizi; Koorosh Rahmani
Journal:  Iran J Radiol       Date:  2015-09-29       Impact factor: 0.212

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.